Slide 1NON METASTATIC OSTEOSARCOMA. EXPERIENCE AT SKMCH & RC ALIA ZAIDI, AHSAN SHAMIM, WASILA SHAMIM SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE Slide…

1. “ Experience in the Field” Vietnam 2002-2010 Irish Medical OrganisationAGM2010 2. Experience to Date Background Ghana 1983-1984 Vietnam 2003-Date Tanzania 2008-Date…

Slide 1 Pulmonary Neoplasia Prof. Frank Carey Slide 2 Lung Neoplasms r Primary l benign (rare) l malignant (very common) r Metastatic (Very common) Slide 3 Male 21 – metastatic…

15th Annual CTOS Meeting November 5â7, 2009 PRELIMINARY RESULTS OF A RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY WITH METHOTREXATE (MTX), CISPLATIN (CDP), DOXORUBICIN (ADM),…

pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcomaprognostic and a predictive biomarker for patients with